Blood tests for Down syndrome during pregnancy are highly accurate, but they are screening tests, not diagnostic ones. The most widely used option, called cell-free DNA screening (often referred to as NIPT), detects over 99% of Down syndrome cases and has a false positive rate below 0.1%. That means the test catches nearly every affected pregnancy, and it rarely flags a pregnancy that isn’t affected. Still, a positive result is not a definitive diagnosis, and confirmatory testing is needed before making any decisions based on the result.
How Cell-Free DNA Screening Works
During pregnancy, fragments of DNA from the placenta circulate in the mother’s bloodstream. A simple blood draw, typically done after 10 weeks of pregnancy, captures these fragments and analyzes them for extra copies of chromosome 21, which causes Down syndrome. The test looks at proportions of chromosomal material rather than directly examining the baby’s cells, which is why it’s classified as a screening tool rather than a diagnostic one.
Results usually come back within one to two weeks. You’ll receive either a “low risk” or “high risk” result rather than a simple yes or no.
Detection Rates and False Positives
Across large studies involving more than 23,000 pregnancies, cell-free DNA screening detected 99.3% of Down syndrome cases. Specificity, the test’s ability to correctly identify unaffected pregnancies, was 99.96%. In practical terms, out of those 23,000+ pregnancies, only 10 produced a false positive result for Down syndrome.
These numbers make cell-free DNA screening significantly more accurate than older blood-based methods. Traditional first-trimester screening, done between 11 and 13 weeks, measures two proteins in the mother’s blood and combines the results with an ultrasound. The quad screen, offered between 15 and 20 weeks, measures four proteins. Both of these older methods detect a smaller proportion of affected pregnancies and produce more false alarms. The American College of Obstetricians and Gynecologists now recommends cell-free DNA as the most sensitive and specific screening test for Down syndrome and advises that it be routinely available to all pregnant patients, regardless of age or risk level.
What a Positive Result Actually Means
A “high risk” result does not mean your baby has Down syndrome. The number that matters here is called the positive predictive value (PPV): the likelihood that a positive screening result reflects a true case. For Down syndrome specifically, the PPV ranges from about 90% to 97% depending on maternal age. Women under 30 see a PPV around 90.5%, while women 40 and older see values closer to 97.6%. Even at the high end, that means roughly 2 to 3 out of every 100 positive results are false alarms.
Your age matters because Down syndrome becomes more common with increasing maternal age, and when a condition is more common in a population, a positive test is more likely to be correct. But the gap is smaller than many people expect. One large analysis found overall PPVs of 90.9% for women under 35 and 94.5% for women 35 and older.
Why False Positives Happen
The test reads DNA from the placenta, not directly from the baby, and sometimes the placenta’s chromosomes don’t match the baby’s. This is called confined placental mosaicism, and it’s the most common biological cause of a false positive. The placenta carries an extra copy of chromosome 21, triggering a high-risk result, while the baby’s chromosomes are completely normal.
Other causes include vanishing twin syndrome, where a twin that stopped developing early in pregnancy had a chromosomal difference and its DNA fragments still circulate in the mother’s blood. Certain maternal conditions can also interfere, including uterine fibroids, unrecognized chromosomal mosaicism in the mother herself, and in rare cases, an undiagnosed maternal cancer that sheds abnormal DNA into the bloodstream.
Confirming the Result
Any positive screening result should be followed by a diagnostic test before drawing conclusions. The two options are chorionic villus sampling (CVS), performed in the first trimester, and amniocentesis, performed in the second trimester. Both carry a miscarriage risk of less than 0.5%.
Amniocentesis is generally considered the more reliable confirmation. It samples fluid surrounding the baby, which contains actual fetal cells. Studies of over 5,000 patients found that amniocentesis correctly identified 100% of Down syndrome cases. CVS, which samples placental tissue, can occasionally be affected by the same placental mosaicism that causes false positives on the blood test. There are documented cases where CVS indicated Down syndrome, amniocentesis came back normal, and the baby was unaffected at birth. For this reason, when a CVS result is unclear or unexpected, amniocentesis is often recommended as a follow-up.
Older Screening Methods Still in Use
Not every pregnancy uses cell-free DNA screening. Some patients start with first-trimester combined screening (a blood draw plus a nuchal translucency ultrasound at 11 to 13 weeks) or the quad screen (a blood draw at 15 to 20 weeks). These tests are less expensive and more widely available in some healthcare systems, but they detect fewer cases and produce more false positives than cell-free DNA screening. If either of these older tests comes back with an elevated risk, your provider may recommend cell-free DNA screening as a next step before moving to an invasive diagnostic procedure.
What the Numbers Mean for You
If you receive a low-risk cell-free DNA result for Down syndrome, the chance of a missed case is extremely small, well under 1%. If you receive a high-risk result, there’s roughly a 90 to 97% chance the result is correct, but that still leaves a meaningful possibility it’s wrong. The only way to know for certain is through amniocentesis or CVS. No blood-based screening test, no matter how advanced, replaces a diagnostic test when a definitive answer is needed.